What clinical trials are available for early stage Ovarian Cancer

Clinical Trials for Early-Stage Ovarian Cancer

I appreciate your question about clinical trial options. Let me provide you with educational information about what's available, based on current medical guidelines.

What the Guidelines Say About Early-Stage Ovarian Cancer Treatment

According to the NCCN Guidelines for Ovarian Cancer (Version 3.2025), early-stage ovarian cancer treatment typically involves:

1. Primary cytoreductive surgery (removing the tumor and affected tissue)
2. Adjuvant chemotherapy (chemotherapy after surgery to reduce recurrence risk)
3. Potential maintenance therapy depending on your specific cancer characteristics

Clinical Trial Landscape for Early-Stage Disease

The NCCN Guidelines reference several important clinical trials that have shaped treatment approaches:

• SOLO1 Trial: Evaluated maintenance olaparib (a PARP inhibitor) for patients with newly diagnosed advanced ovarian cancer who have a BRCA mutation
• PAOLA-1 Trial: Studied maintenance olaparib plus bevacizumab after chemotherapy for newly diagnosed advanced high-grade ovarian cancer

However, the guidelines note that data are limited for early-stage disease specifically, and most major trials have focused on advanced-stage cancer.

Finding Trials Specific to Your Situation

To locate clinical trials appropriate for early-stage ovarian cancer, I recommend:

Questions to ask your oncology team:

1. "Are there any clinical trials at this institution for early-stage ovarian cancer patients with my specific cancer type and biomarkers?"
2. "Should I have genetic testing (BRCA, HRD status) before considering trial eligibility?"
3. "Are there trials testing maintenance therapy approaches for early-stage disease?"
4. "Can you refer me to ClinicalTrials.gov or help me search for relevant studies?"

Important Resources

• ClinicalTrials.gov: Search "ovarian cancer" + "early stage" to find actively enrolling studies
• NCCN Member Institutions: Often have access to institutional trials
• Cancer advocacy organizations: Groups like the Ovarian Cancer Research Alliance may have trial-matching resources

Why This Matters

According to NCCN Guidelines, identifying your cancer's molecular characteristics (BRCA status, HRD status, biomarkers) early can help determine which maintenance therapy approaches—including potential clinical trials—might benefit you most.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial eligibility.